The most notable strategic choice is prioritising myasthenia gravis (MG) and Sjögren's disease as lead indications while ...

Some people get drunk without drinking because their gut bacteria produce alcohol from food. Researchers have now identified the microbes and biological pathways behind this rare condition, ...

Beam Therapeutics Inc. pivots from platform story to execution-driven thesis, with regulatory clarity accelerating BEAM-302 ...

Trained on 9.7 trillion tokens of evolutionary data, EDEN designs therapeutics from large gene insertion to antimicrobial peptides.

Hair loss–focused Veradermics and cancer biotech Eikon follow the lead of Aktis Oncology, which last week announced a $318 ...

The company also announced the appointment of Han Lee, Ph.D., as co-chief executive officer (CEO), and the U.S. Food and Drug ...

After greenlighting 56 novel therapeutics in 2025, four notable applications continue to await the agency’s action after ...

The collaboration will leverage Abalone Bio’s Functional Antibody Selection Technology platform for an undisclosed ...

Parabilis Medicines raised $305 million in a Series F round led by RA Capital, Fidelity and Janus Henderson, with crossover ...

Neuroimmune diseases, such as multiple sclerosis, myasthenia gravis, and autoimmune encephalitis, are debilitating conditions ...

A successful Phase 3 trial and a public offeringof stock boosted prospects for this company to receive approval for an ...

NTx Bio, a leader in next-generation biomanufacturing technologies, today announced that Joan Haab, Ph.D., has been appointed ...